These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 27271370)
1. Impact of Experimental Conditions on the Evaluation of Interactions between Multidrug and Toxin Extrusion Proteins and Candidate Drugs. Lechner C; Ishiguro N; Fukuhara A; Shimizu H; Ohtsu N; Takatani M; Nishiyama K; Washio I; Yamamura N; Kusuhara H Drug Metab Dispos; 2016 Aug; 44(8):1381-9. PubMed ID: 27271370 [TBL] [Abstract][Full Text] [Related]
2. Impact of Direction of Transport on the Evaluation of Inhibition Potencies of Multidrug and Toxin Extrusion Protein 1 Inhibitors. Saito A; Ishiguro N; Takatani M; Bister B; Kusuhara H Drug Metab Dispos; 2021 Feb; 49(2):152-158. PubMed ID: 33262224 [TBL] [Abstract][Full Text] [Related]
3. Competitive inhibition of the luminal efflux by multidrug and toxin extrusions, but not basolateral uptake by organic cation transporter 2, is the likely mechanism underlying the pharmacokinetic drug-drug interactions caused by cimetidine in the kidney. Ito S; Kusuhara H; Yokochi M; Toyoshima J; Inoue K; Yuasa H; Sugiyama Y J Pharmacol Exp Ther; 2012 Feb; 340(2):393-403. PubMed ID: 22072731 [TBL] [Abstract][Full Text] [Related]
4. Role of organic cation transporter OCT2 and multidrug and toxin extrusion proteins MATE1 and MATE2-K for transport and drug interactions of the antiviral lamivudine. Müller F; König J; Hoier E; Mandery K; Fromm MF Biochem Pharmacol; 2013 Sep; 86(6):808-15. PubMed ID: 23876341 [TBL] [Abstract][Full Text] [Related]
5. Double-transfected MDCK cells expressing human OCT1/MATE1 or OCT2/MATE1: determinants of uptake and transcellular translocation of organic cations. König J; Zolk O; Singer K; Hoffmann C; Fromm MF Br J Pharmacol; 2011 Jun; 163(3):546-55. PubMed ID: 20883471 [TBL] [Abstract][Full Text] [Related]
6. Contribution of MATE1 to Renal Secretion of the NMDA Receptor Antagonist Memantine. Müller F; Weitz D; Derdau V; Sandvoss M; Mertsch K; König J; Fromm MF Mol Pharm; 2017 Sep; 14(9):2991-2998. PubMed ID: 28708400 [TBL] [Abstract][Full Text] [Related]
7. Proguanil and cycloguanil are organic cation transporter and multidrug and toxin extrusion substrates. van der Velden M; Bilos A; van den Heuvel JJMW; Rijpma SR; Hurkmans EGE; Sauerwein RW; Russel FGM; Koenderink JB Malar J; 2017 Oct; 16(1):422. PubMed ID: 29061131 [TBL] [Abstract][Full Text] [Related]
8. Substrate-dependent ligand inhibition of the human organic cation transporter OCT2. Belzer M; Morales M; Jagadish B; Mash EA; Wright SH J Pharmacol Exp Ther; 2013 Aug; 346(2):300-10. PubMed ID: 23709117 [TBL] [Abstract][Full Text] [Related]
9. Efavirenz reduces renal excretion of lamivudine in rats by inhibiting organic cation transporters (OCT, Oct) and multidrug and toxin extrusion proteins (MATE, Mate). Ceckova M; Reznicek J; Deutsch B; Fromm MF; Staud F PLoS One; 2018; 13(8):e0202706. PubMed ID: 30114293 [TBL] [Abstract][Full Text] [Related]
10. Interaction of human multidrug and toxin extrusion 1 (MATE1) transporter with antineoplastic agents. Grottker J; Rosenberger A; Burckhardt G; Hagos Y Drug Metabol Drug Interact; 2011; 26(4):181-9. PubMed ID: 22149660 [TBL] [Abstract][Full Text] [Related]
11. Moxifloxacin Is a Potent In Vitro Inhibitor of OCT- and MATE-Mediated Transport of Metformin and Ethambutol. Te Brake LH; van den Heuvel JJ; Buaben AO; van Crevel R; Bilos A; Russel FG; Aarnoutse RE; Koenderink JB Antimicrob Agents Chemother; 2016 Dec; 60(12):7105-7114. PubMed ID: 27645247 [TBL] [Abstract][Full Text] [Related]
12. Substrate-Dependent Inhibition of the Human Organic Cation Transporter OCT2: A Comparison of Metformin with Experimental Substrates. Hacker K; Maas R; Kornhuber J; Fromm MF; Zolk O PLoS One; 2015; 10(9):e0136451. PubMed ID: 26327616 [TBL] [Abstract][Full Text] [Related]
13. Substrate-dependent inhibition of human MATE1 by cationic ionic liquids. Martínez-Guerrero LJ; Wright SH J Pharmacol Exp Ther; 2013 Sep; 346(3):495-503. PubMed ID: 23785176 [TBL] [Abstract][Full Text] [Related]
14. The Use of Transporter Probe Drug Cocktails for the Assessment of Transporter-Based Drug-Drug Interactions in a Clinical Setting-Proposal of a Four Component Transporter Cocktail. Ebner T; Ishiguro N; Taub ME J Pharm Sci; 2015 Sep; 104(9):3220-8. PubMed ID: 25981193 [TBL] [Abstract][Full Text] [Related]
15. Molecular determinants of ligand selectivity for the human multidrug and toxin extruder proteins MATE1 and MATE2-K. Astorga B; Ekins S; Morales M; Wright SH J Pharmacol Exp Ther; 2012 Jun; 341(3):743-55. PubMed ID: 22419765 [TBL] [Abstract][Full Text] [Related]
16. Ondansetron can enhance cisplatin-induced nephrotoxicity via inhibition of multiple toxin and extrusion proteins (MATEs). Li Q; Guo D; Dong Z; Zhang W; Zhang L; Huang SM; Polli JE; Shu Y Toxicol Appl Pharmacol; 2013 Nov; 273(1):100-9. PubMed ID: 24001450 [TBL] [Abstract][Full Text] [Related]
17. Mechanistic in vitro studies confirm that inhibition of the renal apical efflux transporter multidrug and toxin extrusion (MATE) 1, and not altered absorption, underlies the increased metformin exposure observed in clinical interactions with cimetidine, trimethoprim or pyrimethamine. Elsby R; Chidlaw S; Outteridge S; Pickering S; Radcliffe A; Sullivan R; Jones H; Butler P Pharmacol Res Perspect; 2017 Oct; 5(5):. PubMed ID: 28971610 [TBL] [Abstract][Full Text] [Related]
18. Impact of Substrate-Dependent Inhibition on Renal Organic Cation Transporters hOCT2 and hMATE1/2-K-Mediated Drug Transport and Intracellular Accumulation. Yin J; Duan H; Wang J J Pharmacol Exp Ther; 2016 Dec; 359(3):401-410. PubMed ID: 27758931 [TBL] [Abstract][Full Text] [Related]
19. Cationic Compounds with SARS-CoV-2 Antiviral Activity and Their Interaction with Organic Cation Transporter/Multidrug and Toxin Extruder Secretory Transporters. Martinez-Guerrero L; Zhang X; Zorn KM; Ekins S; Wright SH J Pharmacol Exp Ther; 2021 Oct; 379(1):96-107. PubMed ID: 34253645 [TBL] [Abstract][Full Text] [Related]
20. Identification of multidrug and toxin extrusion (MATE1 and MATE2-K) variants with complete loss of transport activity. Kajiwara M; Terada T; Ogasawara K; Iwano J; Katsura T; Fukatsu A; Doi T; Inui K J Hum Genet; 2009 Jan; 54(1):40-6. PubMed ID: 19158817 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]